University of California, San Diego, United States.
Best Pract Res Clin Anaesthesiol. 2017 Jun;31(2):189-200. doi: 10.1016/j.bpa.2017.07.006. Epub 2017 Jul 25.
Cardiac transplantation is the treatment of choice for patients with end-stage heart failure. Over the years, significant advances in patient selection, donor optimization and selection, and optimization of immunosuppression strategies have markedly improved outcomes. In this review, we highlight patient selection, donor management and procurement, heart transplantation procedure, and intraoperative and postoperative management of heart transplants.
心脏移植是治疗终末期心力衰竭患者的首选方法。多年来,在患者选择、供者优化和选择以及免疫抑制策略优化方面取得了重大进展,显著改善了预后。在这篇综述中,我们重点介绍了患者选择、供者管理和获取、心脏移植手术以及心脏移植的术中及术后管理。